Improvement in some but not all domains of cognition during treatment with ... The Brief Psychiatric Rating Scale (BPRS) was used to assess psychopathology in patients treated with typical ...

Opens in a new tab or window No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia ... the wide variety of scales used in the ...

The effect of Caplyta was measured using a rating scale that evaluates how severe schizophrenia symptoms are. Higher scores mean more severe symptoms. Most people had severe symptoms of ...

The study found that in patients with schizophrenia, a decline in social cognition—a fundamental skill for interpersonal ...

Some recent, large-scale studies have ... outcome in patients with schizophrenia. Atypical antipsychotic drugs have been shown to be more efficacious in treating cognitive disturbances of ...

Treatment for schizophrenia typically involves medications along with psychosocial therapies like cognitive behavioral therapy (CBT), which often let people with the disorder live fulfilling ...

I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community. Historically ...

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the ...

This latest investment builds on the funding announced on 23 April 2024 and will help support the clinical development of MT1988, a novel treatment for the cognitive symptoms of schizophrenia. If ...

Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia ... The study looked at cognitive, brain and genetic data for more than ...